JAK2 and SHP2 reciprocally regulate tyrosine phosphorylation and stability of proapoptotic protein ASK1

Luyang Yu1, Wang Min2, Yun He1

  • 1Interdepartmental Program in Vascular Biology and Therapeutics, Department of Pathology, Yale University School of Medicine, New Haven, Connecticut 06520.

Insights

Janus kinase 2 (JAK2) and Src homology 2 domain-containing phosphatase-2 (SHP2) reciprocally regulate apoptosis signal-regulating kinase 1 (ASK1) phosphorylation and stability. JAK2 promotes ASK1 degradation, while SHP2 dephosphorylates and stabilizes ASK1.

Area of Science:

  • Cellular signaling pathways
  • Protein regulation and degradation
  • Cytokine-mediated cellular responses

Background:

  • Apoptosis signal-regulating kinase 1 (ASK1) degradation is mediated by Suppressor of Cytokine Signaling 1 (SOCS1) binding to phosphorylated Tyrosine 718 (Tyr-718).
  • The specific kinase and phosphatase regulating ASK1 phosphorylation and dephosphorylation at Tyr-718 were previously unidentified.

Purpose of the Study:

  • To identify the kinase and phosphatase responsible for ASK1 phosphorylation and dephosphorylation at Tyr-718.
  • To elucidate the roles of these enzymes in regulating ASK1 stability and downstream signaling in response to cytokines.

Main Methods:

  • Utilized specific kinase inhibitors and phosphatase-inactive mutants.
  • Investigated protein-protein interactions using co-immunoprecipitation assays.
  • Employed knockout endothelial cells (EC) deficient in SOCS1 or SHP2.
  • Assessed protein phosphorylation and degradation via Western blotting and proteasomal inhibition.

Main Results:

  • Identified Janus kinase 2 (JAK2) as the Tyr-718-specific kinase and Src homology 2 domain-containing phosphatase-2 (SHP2) as the Tyr-718-specific phosphatase for ASK1.
  • JAK2 directly phosphorylates ASK1 at Tyr-718, promoting SOCS1 binding and subsequent ASK1 degradation, particularly induced by Interferon-gamma (IFN-gamma).
  • SHP2 dephosphorylates ASK1 at Tyr-718, dissociates SOCS1, enhances ASK1 stability, and regulates ASK1-JNK signaling and endothelial cell (EC) apoptosis, especially in response to Tumor Necrosis Factor (TNF).

Conclusions:

  • JAK2 and SHP2 act as reciprocal regulators of ASK1 phosphorylation and stability.
  • These findings reveal a novel regulatory mechanism for ASK1 in response to diverse cytokine signals, impacting cellular fate.
  • The interplay between JAK2-SOCS1 and SHP2 provides critical insights into ASK1-mediated cellular processes.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...